Publication | Closed Access

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Molecular SubtypingUrologyGenitourinary CancerMedicineImmunologyImmune InfiltrationMuscle-invasive Bladder CancerImmune Checkpoint InhibitorCancer TreatmentOncologyTumor Microenvironment